Ischemic placental disease and risks of perinatal mortality and morbidity and neurodevelopmental outcomes

Seminars in Perinatology

Volumn 38, Issue 3, 2014, Pages 151-158

  Ananth, Cande V ^a,b   Friedman, Alexander M ^a  

^a Department of Obstetrics and Gynecology College of Physicians and Surgeons Columbia University ^*  (United States)

^b Department of Medicine   (United States)

Author keywords

Intrauterine growth restriction; Ischemic placental disease; Neurodevelopmental outcomes; Perinatal mortality; Placental abruption; Preeclampsia; Stillbirth

Indexed keywords

BEHAVIOR DISORDER; BRAIN HEMORRHAGE; COGNITIVE DEFECT; HUMAN; INFANT MORTALITY; INTRAUTERINE GROWTH RETARDATION; ISCHEMIC PLACENTAL DISEASE; MOTOR DYSFUNCTION; NEWBORN MORBIDITY; NEWBORN MORTALITY; PERINATAL MORBIDITY; PERINATAL MORTALITY; PLACENTA DISORDER; PREECLAMPSIA; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RISK REDUCTION; SMALL FOR DATE INFANT; SOLUTIO PLACENTAE; STILLBIRTH; CHILD DEVELOPMENT; COMPLICATION; EPIDEMIOLOGY; FEMALE; FETAL GROWTH RETARDATION; ISCHEMIA; MORTALITY; NEURODEGENERATIVE DISEASES; NEWBORN; PLACENTA; PLACENTA DISEASES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREVALENCE; VASCULARIZATION;

ABRUPTIO PLACENTAE; CHILD DEVELOPMENT; FEMALE; FETAL GROWTH RETARDATION; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; ISCHEMIA; NEURODEGENERATIVE DISEASES; PERINATAL MORTALITY; PLACENTA; PLACENTA DISEASES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREVALENCE; RISK FACTORS; STILLBIRTH;

EID: 84900444949     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2014.03.007     Document Type: Review

References (82)

1. Ananth C.V., Vintzileos A.M. Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth. Am J Obstet Gynecol 2006, 195:1557-1563.
2. Ananth C.V., Vintzileos A.M. Medically indicated preterm birth: recognizing the importance of the problem. Clin Perinatol 2008, 35:53-67.
3. Ananth C.V., Joseph K.S., Kinzler W.L. The influence of obstetric intervention on trends in twin stillbirths: United States, 1989-99. J Matern Fetal Neonatal Med 2004, 15:380-387.
4. Ananth C.V., Joseph K.S., Oyelese Y., Demissie K., Vintzileos A.M. Trends in preterm birth and perinatal mortality among singletons: United States, 1989 through 2000. Obstet Gynecol 2005, 105:1084-1091.
5. Barros F.C., Velez Mdel P. Temporal trends of preterm birth subtypes and neonatal outcomes. Obstet Gynecol 2006, 107:1035-1041.
6. Lisonkova S., Hutcheon J.A., Joseph K.S. Temporal trends in neonatal outcomes following iatrogenic preterm delivery. BMC Pregnancy Childbirth 2011, 11:39.
7. Barber E.L., Lundsberg L.S., Belanger K., Pettker C.M., Funai E.F., Illuzzi J.L. Indications contributing to the increasing cesarean delivery rate. Obstet Gynecol 2011, 118:29-38.
8. Basso O., Rasmussen S., Weinberg C.R., Wilcox A.J., Irgens L.M., Skjaerven R. Trends in fetal and infant survival following preeclampsia. J Am Med Assoc 2006, 296:1357-1362.
9. Lisonkova S., Joseph K.S. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol 2013, 209(544):e1-e12.
10. Chen X.K., Wen S.W., Smith G., Yang Q., Walker M. Pregnancy-induced hypertension is associated with lower infant mortality in preterm singletons. BJOG 2006, 113:544-551.
11. Ananth C.V., Basso O. Impact of pregnancy-induced hypertension on stillbirth and neonatal mortality. Epidemiology 2010, 21:118-123.
12. Hutcheon J.A., Lisonkova S., Joseph K.S. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 2011, 25:391-403.
13. Piper J.M., Xenakis E.M., McFarland M., Elliott B.D., Berkus M.D., Langer O. Do growth-retarded premature infants have different rates of perinatal morbidity and mortality than appropriately grown premature infants?. Obstet Gynecol 1996, 87:169-174.
14. Gardosi J., Madurasinghe V., Williams M., Malik A., Francis A. Maternal and fetal risk factors for stillbirth: population based study. Br Med J 2013, 346:f108.
15. Getahun D., Ananth C.V., Kinzler W.L. Risk factors for antepartum and intrapartum stillbirth: a population-based study. Am J Obstet Gynecol 2007, 196:499-507.
16. Ego A., Subtil D., Grange G., Thiebaugeorges O., Senat M.V., Vayssiere C., et al. Customized versus population-based birth weight standards for identifying growth restricted infants: a French multicenter study. Am J Obstet Gynecol 2006, 194:1042-1049.
17. Malloy M.H., Freeman D.H. Birth weight- and gestational age-specific sudden infant death syndrome mortality: United States, 1991 versus 1995. Pediatrics 2000, 105:1227-1231.
18. Williams R.L., Creasy R.K., Cunningham G.C., Hawes W.E., Norris F.D., Tashiro M. Fetal growth and perinatal viability in California. Obstet Gynecol 1982, 59:624-632.
19. Kok J.H., den Ouden A.L., Verloove-Vanhorick S.P., Brand R. Outcome of very preterm small for gestational age infants: the first nine years of life. Br J Obstet Gynaecol 1998, 105:162-168.
20. Group G.S. A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and Bayesian interpretation. BJOG 2003, 110:27-32.
21. Ananth C.V., VanderWeele T.J. Placental abruption and perinatal mortality with preterm delivery as a mediator: disentangling direct and indirect effects. Am J Epidemiol 2011, 174:99-108.
22. Ananth C.V., Wilcox A.J. Placental abruption and perinatal mortality in the United States. Am J Epidemiol 2001, 153:332-337.
23. Rasmussen S., Irgens L.M., Bergsjo P., Dalaker K. Perinatal mortality and case fatality after placental abruption in Norway 1967-1991. Acta Obstet Gynecol Scand 1996, 75:229-234.
24. Tikkanen M., Luukkaala T., Gissler M., Ritvanen A., Ylikorkala O., Paavonen J., et al. Decreasing perinatal mortality in placental abruption. Acta Obstet Gynecol Scand 2013, 92:298-305.
25. Ross M.G., Downey C.A., Bemis-Heys R., Nguyen M., Jacques D.L., Stanziano G. Prediction by maternal risk factors of neonatal intensive care admissions: evaluation of >59,000 women in national managed care programs. Am J Obstet Gynecol 1999, 181:835-842.
26. Churchill D., Duley L., Thornton J.G., Jones L. Interventionist versus expectant care for severe pre-eclampsia between 24 and 34 weeks' gestation. Cochrane Database Syst Rev 2013, 7. [CD003106].
27. Jenkins S.M., Head B.B., Hauth J.C. Severe preeclampsia at <25 weeks of gestation: maternal and neonatal outcomes. Am J Obstet Gynecol 2002, 186:790-795.
28. Gray P.H., Hurley T.M., Rogers Y.M., O'Callaghan M.J., Tudehope D.I., Burns Y.R., et al. Survival and neonatal and neurodevelopmental outcome of 24-29 week gestation infants according to primary cause of preterm delivery. Aust N Z J Obstet Gynaecol 1997, 37:161-168.
29. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013, 122:1122-1131. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy.
30. Wolf E.J., Vintzileos A.M., Rosenkrantz T.S., Rodis J.F., Salafia C.M., Pezzullo J.G. Do survival and morbidity of very-low-birth-weight infants vary according to the primary pregnancy complication that results in preterm delivery?. Am J Obstet Gynecol 1993, 169:1233-1239.
31. Kimberlin D.F., Hauth J.C., Owen J., Bottoms S.F., Iams J.D., Mercer B.M., et al. Indicated versus spontaneous preterm delivery: an evaluation of neonatal morbidity among infants weighing
32. Habli M., Levine R.J., Qian C., Sibai B. Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. Am J Obstet Gynecol 2007, 197(406):e1-e7.
33. Langenveld J., Ravelli A.C., van Kaam A.H., van der Ham D.P., van Pampus M.G., Porath M., et al. Neonatal outcome of pregnancies complicated by hypertensive disorders between 34 and 37 weeks of gestation: a 7 year retrospective analysis of a national registry. Am J Obstet Gynecol 2011, 205(540):e1-e7.
34. Hiett A.K., Brown H.L., Britton K.A. Outcome of infants delivered between 24 and 28 weeks' gestation in women with severe pre-eclampsia. J Matern Fetal Med 2001, 10:301-304.
35. Doctor B.A., O'Riordan M.A., Kirchner H.L., Shah D., Hack M. Perinatal correlates and neonatal outcomes of small for gestational age infants born at term gestation. Am J Obstet Gynecol 2001, 185:652-659.
36. Tenovuo A., Kero P., Korvenranta H., Piekkala P., Sillanpaa M., Erkkola R. Developmental outcome of 519 small-for-gestational age children at the age of two years. Neuropediatrics 1988, 19:41-45.
37. Simchen M.J., Beiner M.E., Strauss-Liviathan N., et al. Neonatal outcome in growth-restricted versus appropriately grown preterm infants. Am J Perinatol 2000, 17:187-192.
38. Sharma P., McKay K., Rosenkrantz T.S., Hussain N. Comparisons of mortality and pre-discharge respiratory outcomes in small-for-gestational-age and appropriate-for-gestational-age premature infants. BMC Pediatr 2004, 4:9.
39. Zeitlin J., El Ayoubi M., Jarreau P.H., et al. Impact of fetal growth restriction on mortality and morbidity in a very preterm birth cohort. J Pediatr 2010, 157(733-9):e1.
40. Peacock J.L., Lo J.W., D'Costa W., Calvert S., Marlow N., Greenough A. Respiratory morbidity at follow-up of small-for-gestational-age infants born very prematurely. Pediatr Res 2013, 73:457-463.
41. Bernstein I.M., Horbar J.D., Badger G.J., Ohlsson A., Golan A. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network. Am J Obstet Gynecol 2000, 182:198-206.
42. Gray P.H., Rodwell R.L. Neonatal neutropenia associated with maternal hypertension poses a risk for nosocomial infection. Eur J Pediatr 1999, 158:71-73.
43. Mouzinho A., Rosenfeld C.R., Sanchez P.J., Risser R. Effect of maternal hypertension on neonatal neutropenia and risk of nosocomial infection. Pediatrics 1992, 90:430-435.
44. Tyson J.E., Kennedy K., Broyles S., Rosenfeld C.R. The small for gestational age infant: accelerated or delayed pulmonary maturation? Increased or decreased survival?. Pediatrics 1995, 95:534-538.
45. Ananth C.V., Berkowitz G.S., Savitz D.A., Lapinski R.H. Placental abruption and adverse perinatal outcomes. J Am Med Assoc 1999, 282:1646-1651.
46. Tikkanen M., Nuutila M., Hiilesmaa V., Paavonen J., Ylikorkala O. Clinical presentation and risk factors of placental abruption. Acta Obstet Gynecol Scand 2006, 85:700-705.
47. Tikkanen M., Nuutila M., Hiilesmaa V., Paavonen J., Ylikorkala O. Prepregnancy risk factors for placental abruption. Acta Obstet Gynecol Scand 2006, 85:40-44.
48. Gabbay-Benziv R., Maman M., Wiznitzer A., Linder N., Yogev Y. Umbilical cord prolapse during delivery - risk factors and pregnancy outcome: a single center experience. J Matern Fetal Neonatal Med 2014, 27:14-17.
49. Pariente G., Wiznitzer A., Sergienko R., Mazor M., Holcberg G., Sheiner E. Placental abruption: critical analysis of risk factors and perinatal outcomes. J Matern Fetal Neonatal Med 2011, 24:698-702.
50. Usui R., Matsubara S., Ohkuchi A., Kuwata T., Watanabe T., Izumi A., et al. Fetal heart rate pattern reflecting the severity of placental abruption. Arch Gynecol Obstet 2008, 277:249-253.
51. Heinonen S., Saarikoski S. Reproductive risk factors of fetal asphyxia at delivery: a population based analysis. J Clin Epidemiol 2001, 54:407-410.
52. Kayani S.I., Walkinshaw S.A., Preston C. Pregnancy outcome in severe placental abruption. BJOG 2003, 110:679-683.
53. Cheng S.W., Chou H.C., Tsou K.I., Fang L.J., Tsao P.N. Delivery before 32 weeks of gestation for maternal pre-eclampsia: neonatal outcome and 2-year developmental outcome. Early Hum Dev 2004, 76:39-46.
54. Many A., Fattal A., Leitner Y., Kupferminc M.J., Harel S., Jaffa A. Neurodevelopmental and cognitive assessment of children born growth restricted to mothers with and without preeclampsia. Hypertens Pregnancy 2003, 22:25-29.
55. Spinillo A., Iasci A., Capuzzo E., Egbe T.O., Colonna L., Fazzi E. Two-year infant neurodevelopmental outcome after expectant management and indicated preterm delivery in hypertensive pregnancies. Acta Obstet Gynecol Scand 1994, 73:625-629.
56. Leitner Y., Fattal-Valevski A., Geva R., Bassan H., Posner E., Kutai M., et al. Six-year follow-up of children with intrauterine growth retardation: long-term, prospective study. J Child Neurol 2000, 15:781-786.
57. Baschat A.A. Neurodevelopment following fetal growth restriction and its relationship with antepartum parameters of placental dysfunction. Ultrasound Obstet Gynecol 2011, 37:501-514.
58. Markestad T., Vik T., Ahlsten G., Skjaerven R., Jacobsen G., Hoffman H.J., et al. Small-for-gestational-age (SGA) infants born at term: growth and development during the first year of life. Acta Obstet Gynecol Scand Suppl 1997, 165:93-101.
59. Sommerfelt K., Andersson H.W., Sonnander K., Ahlsten G., Ellertsen B., Markestad T., et al. Behavior in term, small for gestational age preschoolers. Early Hum Dev 2001, 65:107-121.
60. Sommerfelt K., Andersson H.W., Sonnander K., Ahlsten G., Ellertsen B., Markestad T., et al. Cognitive development of term small for gestational age children at five years of age. Arch Dis Child 2000, 83:25-30.
61. Strauss R.S. Adult functional outcome of those born small for gestational age: twenty-six-year follow-up of the 1970 British Birth Cohort. J Am Med Assoc 2000, 283:625-632.
62. Bergvall N., Iliadou A., Johansson S., Tuvemo T., Cnattingius S. Risks for low intellectual performance related to being born small for gestational age are modified by gestational age. Pediatrics 2006, 117:e460-e467.
63. Paz I., Gale R., Laor A., Danon Y.L., Stevenson D.K., Seidman D.S. The cognitive outcome of full-term small for gestational age infants at late adolescence. Obstet Gynecol 1995, 85:452-456.
64. Arcangeli T., Thilaganathan B., Hooper R., Khan K.S., Bhide A. Neurodevelopmental delay in small babies at term: a systematic review. Ultrasound Obstet Gynecol 2012, 40:267-275.
65. McCarton C.M., Wallace I.F., Divon M., Vaughan H.G. Cognitive and neurologic development of the premature, small for gestational age infant through age 6: comparison by birth weight and gestational age. Pediatrics 1996, 98:1167-1178.
66. De Jesus L.C., Pappas A., Shankaran S., Li L., Das A., Bell E.F., et al. Outcomes of small for gestational age infants born at <27 weeks' gestation. J Pediatr 2013, 163(55-60):e1-e3.
67. Shand A.W., Hornbuckle J., Nathan E., Dickinson J.E., French N.P. Small for gestational age preterm infants and relationship of abnormal umbilical artery Doppler blood flow to perinatal mortality and neurodevelopmental outcomes. Aust N Z J Obstet Gynaecol 2009, 49:52-58.
68. Figueras F., Cruz-Martinez R., Sanz-Cortes M., Arranz A., Illa M., Botet F., et al. Neurobehavioral outcomes in preterm, growth-restricted infants with and without prenatal advanced signs of brain-sparing. Ultrasound Obstet Gynecol 2011, 38:288-294.
69. van den Broek A.J., Kok J.H., Houtzager B.A., Scherjon S.A. Behavioural problems at the age of eleven years in preterm-born children with or without fetal brain sparing: a prospective cohort study. Early Hum Dev 2010, 86:379-384.
70. Gibbs J.M., Weindling A.M. Neonatal intracranial lesions following placental abruption. Eur J Pediatr 1994, 153:195-197.
71. Spinillo A., Fazzi E., Stronati M., Ometto A., Iasci A., Guaschino S. Severity of abruptio placentae and neurodevelopmental outcome in low birth weight infants. Early Hum Dev 1993, 35:45-54.
72. Matsuda Y., Maeda T., Kouno S. The critical period of non-reassuring fetal heart rate patterns in preterm gestation. Eur J Obstet Gynecol Reprod Biol 2003, 106:36-39.
73. Takano Y., Furukawa S., Ohashi M., Michikata K., Sameshima H., Ikenoue T. Fetal heart rate patterns related to neonatal brain damage and neonatal death in placental abruption. J Obstet Gynaecol Res 2013, 39:61-66.
74. Thorngren-Jerneck K., Herbst A. Perinatal factors associated with cerebral palsy in children born in Sweden. Obstet Gynecol 2006, 108:1499-1505.
75. Ananth C.V., Smulian J.C., Vintzileos A.M. Ischemic placental disease: maternal versus fetal clinical presentations by gestational age. J Matern Fetal Neonatal Med 2010, 23:887-893.
76. Ananth C.V., Vintzileos A.M. Distinguishing pathological from constitutional small for gestational age births in population-based studies. Early Hum Dev 2009, 85:653-658.
77. Helgadottir L.B., Skjeldestad F.E., Jacobsen A.F., Sandset P.M., Jacobsen E.M. Incidence and risk factors of fetal death in Norway: a case-control study. Acta Obstet Gynecol Scand 2011, 90:390-397.
78. Ananth C.V., Cnattingius S. Influence of maternal smoking on placental abruption in successive pregnancies: a population-based prospective cohort study in Sweden. Am J Epidemiol 2007, 166:289-295.
79. Savchev S., Sanz-Cortes M., Cruz-Martinez R., Arranz A., Botet F., Gratacos E., et al. Neurodevelopmental outcome of full-term small-for-gestational-age infants with normal placental function. Ultrasound Obstet Gynecol 2013, 42:201-206.
80. Sung I.K., Vohr B., Oh W. Growth and neurodevelopmental outcome of very low birth weight infants with intrauterine growth retardation: comparison with control subjects matched by birth weight and gestational age. J Pediatr 1993, 123:618-624.
81. Pitaphrom A., Sukcharoen N. Pregnancy outcomes in placental abruption. J Med Assoc Thai 2006, 89:1572-1578.
82. Toivonen S., Heinonen S., Anttila M., Kosma V.M., Saarikoski S. Reproductive risk factors, Doppler findings, and outcome of affected births in placental abruption: a population-based analysis. Am J Perinatol 2002, 19:451-460.